Stoke is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression
Learn more about Stoke’s founders and their vision for helping people with severe genetic diseases caused by loss of function in a single gene.
Our approach is designed to allow us to deliver disease-modifying therapies to a broad range of relevant tissues. Preclinical data have shown our therapies to be highly precise, durable and controllable. See how our TANGO platform works.
We are building a talented team to unite around a common goal – improving the lives of people with severe genetic diseases. Consider joining us.